Highlights from the last week in the Biosphere 🌐
Shopify for Science-Backed Consumer Products
What if the research you heard about on Huberman or saw on Reddit could be rapidly validated, productized and shipped to your front door?
At DeSci Abu Dhabi, Bio CEO @paulkhls, announced Bio is building a platform for consumer products created and validated by research communities in the Bio Network. Think of it as Shopify for open science: a place where self-experimentation meets scientific rigor, and where products aren’t just sold, but continuously tested in the open.
Timed with the post-Christmas wellness wave, various products will debut alongside Ignition Sales for new DeSci projects, uniting purchases, product feedback, and capital formation into a single growth loop.
Initial products will include @Dermadao's skin care products, @Cerebrum_DAO's brain health formulations, @psy_dao's psychedelic tinctures & more.
For consumers, the goal is to replace opaque marketplaces and empty “clinically proven” claims with verifiable provenance - clear sourcing, visible lab data, and real feedback from research communities. For DeSci organizations, it is a direct line to the real world: a place to launch products, learn from real usage, and collect data and insight that feed back into ongoing research.
The world doesn't need another supplement brand. It needs a credible bridge between frontier science and lived experience. More details coming very soon.
Learn more about the vision in the livestream from DeSci Abu Dhabi below ↓
Next Launches on the Bio Launchpad
The next Ignition Sale is coming this Tuesday, December 16: $HOLI by @Holi_Labs. Holi is running the first real-world fitness trial to directly compare Cardio vs. Weight Training on brain health in humans:
100 Berlin gym-goers. 2 training arms. 200+ BDNF blood draws. All data onchain in real time. All revenue and dataset usage feed the Bio Protocol’s buyback & research-funding loop.
➤ Learn more about HOLI by Holi Labs and get your BioXP ready to participate.
Other upcoming DeSci launches on Bio:
- DermaLabs: Research & product engine for skincare innovation
- Ibonova: Ibogaine therapy for PTSD, using synthetic production
- DogYears: Canine longevity therapeutics
- GoCART: Smarter cell therapies for cancer
- VitaSeno: CRISPR gene-editing targeting zombie cells
Bio Preprint Proposes AI Scientist Benchmarks
Bio's AI team published a preprint proposing a new way to evaluate AI Scientists as research co-pilots rather than isolated task executors.
The paper arose from our work evaluating BioAgents, and the realization that current AI for Science benchmarks fail to fully capture the actual workflows of biomedical researchers.
The paper is a clarion call to expand AI for Science benchmarks and adopt workflow benchmarks that stress-test AI like real science does.
We'll introduce a benchmark soon, which addresses some of our paper's concerns.
In the meantime:
➤ Read the paper on @arXiv
➤ Check out BioAgents, our open-source AI Scientist framework.
➤ Read the thread summarizing the findings 👇
Ecosystem
- VitaDAO's VITARNA project shared new in vitro data showing their drug Artan-102 successfully fixes nonsense mutations in test cells with sixfold higher luminescence than control.
- Cerebrum DAO's Transfidelity project is validating newly identified therapeutic targets, testing derivatives of their hit compounds, & prioritizing the most promising targets for drug development.
- HairDAO scaled immunostaining from 16 sections per day, the standard for most labs, to 622 sections in a single day, achieving a 38x increase in data generation in just four months.
- SpineDAO partnered with the AI innovator @pleiasfr to co-build a multi-agent AI stack for spine wellness.
- Curetopia's RAPTOR is the new king of the pill on @pumpdotscience with a 23% lifespan extension in flies.
- D1ckDAO hosted a meetup with Binance Thailand to activate the DeSci scene in Thailand.
- MesoReef DAO released Reef.Regen, an app for the coral restoration community to track progress, contribute data, and build impact records for funding.
- AthenaDAO shared an article diving into their 2025 highlights including their first academic spin-out, demo day, decentralized clinical trials, and what's to come for 2026. Learn more in their End-of-Year Town Hall on Dec 16.
Community
- We hosted DeSci Abu Dhabi with @Molecule_sci, at the Cleveland Clinic featuring: @bettslacroix, CEO of Sam Altman-backed longevity startup @RetroBio_, MIT neuroscience pioneer @eboyden3, Dr. Axel Bouchon from Matter Neuroscience, Pro Athlete James Magnusson & many more.
- Watch the full talk with Joe Betts-LaCroix, CEO of Retro Biosciences, as well as the full live-streamed recording of DeSci Abu Dhabi.
- Solana Breakpoint 2025 featured DeSci Projects setting up wellness booths for participants, including SpineDAO, Pump Science, CUDIS, MoonWalk & more.
- Check out the highlights from our Biotech 2.0 workshop with @CompoundVC.
Explore New DeSci projects on the Bio App
Stay updated via our Telegram, Discord, Governance forum. Follow @BioProtocolEco on X for real-time ecosystem updates.
.webp)
